Amylotect – Faster Alzheimer’s Detection


Amylotect – Calgary, Alberta

A presentation outlining Alzheimer’s disease (AD) and its mechanisms. AD is caused by a build-up of beta-amyloid proteins that initially form in the gut. Current diagnoses use neuroimaging and behavioral assessments, which are inefficient. We propose Amylotect: a tool that uses aptamers to detect beta-amyloid in stool samples. It is a cheap and effective way to diagnose Alzheimer’s, and has the capability of working before symptoms even start.
Team Grade Level: Collegiate
Team Experience Level:
STEM Focus: Synthetic Biology
UN Sustainability Focus:
Prototype Pitch Video:



Posted on

March 12, 2024

Subscribe to our news and updates.

Join our mailing list.

You have Successfully Subscribed!